ArticleCase reports in oncology
A Super-Aged Patient with Primary Cutaneous Gamma-Delta T-Cell Lymphoma Treated with Palliative Radiotherapy: A Short-Term Follow-Up Case.
Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical heterogeneity of primary cutaneous γδ T-cell lymphoma: a 20-year single-institution experience.Blood research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Primary cutaneous gamma-delta T-cell lymphoma (PCGDTL) is a rare and aggressive subtype of cutaneous T-cell lymphoma, often associated with poor prognosis and resistance to conventional therapies. Case Presentation: We present the case of a 91-year-old Japanese man with a 2-month history of rapidly growing, painful nodules on the face, trunk, and extremities. Histopathology showed dermal infiltration by atypical lymphoid cells positive for CD3 and CD5 but negative for cytotoxic markers such as TIA-1 and granzyme B. Flow cytometry confirmed a TCR-γδ+ T-cell phenotype. Given his advanced age, palliative radiotherapy (8 Gy in 4 fractions) was chosen. The treatment was well tolerated and led to dramatic clinical improvement without adverse effects. Conclusion: Although PCGDTL is known for its poor response to both chemotherapy and radiotherapy, this case illustrates the potential of localized radiotherapy as a low-toxicity option that may achieve temporary in selected elderly patients. This report contributes to the limited literature on non-chemotherapy-based management strategies for PCGDTL and highlights the importance of individualized treatment approaches in frail or super-aged patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.